MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead

Link copied toclipboard

• MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
• Admission follows successful IPO for $11.6m from sophisticated and institutional investors
• Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors

The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…

Click here to view the original article.